Title : Combination treatment strategies with a focus on rosiglitazone and adriamycin for insulin resistant liver cancer.

Pub. Date : 2021 Mar

PMID : 33115283






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In vitro assay, ROSI significantly enhanced the inhibitory effects of adriamycin (ADR) on the proliferation, autophagy and migration of insulin-resistant hepatoma HepG2/IR cells via downregulation of EGFR/ERK and AKT/mTOR signaling pathway. Doxorubicin epidermal growth factor receptor Homo sapiens